ÃÛÌÒ´«Ã½app

Anie Philip (PhD) is a full professor at McGill University and a Senior Scientist at the Research Institute of the McGill University Health Center (RI-MUHC). She is currently the President of ‘Skin Research Group of Canada’. Dr Philip is also the Associate Director of the ‘Skin Investigators Network of Canada (SkIN Canada)’. Her most significant contributions include the discovery of CD109 as a TGF-b co-receptor and inhibitor of tissue fibrosis, and the finding that CD109 is a promoter of tumorigenesis in squamous cell carcinoma. Her laboratory is supported by three CIHR Project Grants, a CIHR Network grant, and an NSERC Discovery grant. She has been funded by other agencies including the Department of Defense (DOD), Heart and Stroke Foundation, and Canadian Arthritis Network. Dr Philip collaborates with scientists at the National and International levels and holds grants as a co-applicant with them (New Frontiers in Research fund, Canada, FRQS). Her laboratory has an excellent track record in the training of HQP and typically supervises as the primary supervisor 2-3 PhD students, 2-3 MSc students, 2 PDFs and 2 undergraduates/medical students.